141
Atossa Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
118
FY23:
92.2
FY24:
74.5
FY25:
45.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
5.34
FY23:
4.03
FY24:
1.99
FY25:
1.99
Total assets
Change from FY21 to FY25
millions USD
FY21:
141
FY22:
124
FY23:
96.3
FY24:
76.4
FY25:
47.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.13
FY22:
5.57
FY23:
5.24
FY24:
4.97
FY25:
8.26
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
138
FY22:
118
FY23:
91.0
FY24:
71.5
FY25:
39.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
141
FY22:
124
FY23:
96.3
FY24:
76.4
FY25:
47.6
All amounts in millions USD